Drugs Made In America Acquisition Corp. (DMAAU) Assets (2024 - 2025)
Drugs Made In America Acquisition's (DMAAU) quarterly Assets came in at $239.9 million in Q4 2025, up 43456.35% YoY from N/an in Q4 2024, and up 0.96% on a QoQ basis from $237.6 million in Q3 2025.
Drugs Made In America Acquisition Corp. (DMAAU) Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMAAU) has 2 years of Assets data on file, last reported at $239.9 million in Q4 2025.
- Quarterly Assets rose 43456.35% year-over-year to $239.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $239.9 million (up 43456.35% YoY) and the FY2025 annual result came in at $239.9 million, up 43456.35% from the prior year.
- Assets climbed to $239.9 million in Q4 2025, from $237.6 million in the prior quarter.
- In the past five years, Assets ranged from a high of $239.9 million in Q4 2025 to a low of $550824.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 239.92 Mn |
| Sep 30, 2025 | 237.63 Mn |
| Jun 30, 2025 | 235.21 Mn |
| Mar 31, 2025 | 232.81 Mn |
| Dec 31, 2024 | 550,824.00 |